Vassiliou E[Author] - Search Results

Year	Number of Results
2001	1
2003	2
2004	2
2007	2
2008	1
2009	2
2010	1
2013	3
2014	1
2015	1
2016	1
2018	1
2023	0

1

Topical drug treatment for the dental pulp: an idea whose time has come.

Markowitz K, Vassiliou E. Markowitz K, et al. Among authors: vassiliou e. Quintessence Int. 2013 Jul;44(7):463-5. doi: 10.3290/j.qi.a29790. Quintessence Int. 2013. PMID: 23757465 No abstract available.

2

The origins of entasis: illusion, aesthetics or engineering?

Thompson P, Papadopoulou G, Vassiliou E. Thompson P, et al. Among authors: vassiliou e. Spat Vis. 2007;20(6):531-43. doi: 10.1163/156856807782758359. Spat Vis. 2007. PMID: 18073045

3

A model of hematopoietic bone marrow apoptosis during growth factor deprivation in combination with a cytokine.

Mouser CL, Antoniou ES, Vassiliou EK. Mouser CL, et al. Among authors: vassiliou ek. Theor Biol Med Model. 2018 Jun 21;15(1):8. doi: 10.1186/s12976-018-0080-2. Theor Biol Med Model. 2018. PMID: 29925399 Free PMC article.

4

Dietary docosahexaenoic acid alleviates autistic-like behaviors resulting from maternal immune activation in mice.

Weiser MJ, Mucha B, Denheyer H, Atkinson D, Schanz N, Vassiliou E, Benno RH. Weiser MJ, et al. Among authors: vassiliou e. Prostaglandins Leukot Essent Fatty Acids. 2016 Mar;106:27-37. doi: 10.1016/j.plefa.2015.10.005. Epub 2015 Dec 2. Prostaglandins Leukot Essent Fatty Acids. 2016. PMID: 26703213

5

Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin.

Pettit LK, Varsanyi C, Tadros J, Vassiliou E. Pettit LK, et al. Among authors: vassiliou e. Lipids Health Dis. 2013 Feb 11;12:16. doi: 10.1186/1476-511X-12-16. Lipids Health Dis. 2013. PMID: 23398903 Free PMC article.

6

TH2 lymphocytes secrete functional VIP upon antigen stimulation.

Vassiliou E, Jiang X, Delgado M, Ganea D. Vassiliou E, et al. Arch Physiol Biochem. 2001 Oct;109(4):365-8. doi: 10.1076/apab.109.4.365.4245. Arch Physiol Biochem. 2001. PMID: 11935374

7

Hematopoietic stem cell proliferation modeling under the influence of hematopoietic-inducing agent.

Antoniou ES, Mouser CL, Rosar ME, Tadros J, Vassiliou EK. Antoniou ES, et al. Among authors: vassiliou ek. Shock. 2009 Nov;32(5):471-7. doi: 10.1097/SHK.0b013e3181a1a05f. Shock. 2009. PMID: 19295494

8

Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.

Dimitriadis E, Kalogeropoulos T, Velaeti S, Sotiriou S, Vassiliou E, Fasoulis L, Klapsas V, Synesiou M, Apostolaki A, Trangas T, Pandis N. Dimitriadis E, et al. Among authors: vassiliou e. Anticancer Res. 2013 Jan;33(1):191-7. Anticancer Res. 2013. PMID: 23267145

9

Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells.

Vassiliou E, Jing H, Ganea D. Vassiliou E, et al. Cell Immunol. 2003 Jun;223(2):120-32. doi: 10.1016/s0008-8749(03)00158-8. Cell Immunol. 2003. PMID: 14527510

10

Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells.

Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D. Sheibanie AF, et al. Among authors: vassiliou e. FASEB J. 2004 Aug;18(11):1318-20. doi: 10.1096/fj.03-1367fje. Epub 2004 Jun 4. FASEB J. 2004. PMID: 15180965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results